Haemodynamic management during hyperthermic intraperitoneal chemotherapy: a systematic review
Context Hyperthermic intraperitoneal chemotherapy (HIPEC) is a surgical technique for
peritoneal carcinomatosis combining cytoreduction surgery and peritoneal irrigation of …
peritoneal carcinomatosis combining cytoreduction surgery and peritoneal irrigation of …
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Effects of postoperative fluids beyond the first 24 h
Y Berger, BJ Sullivan, EY Bekhor… - Journal of surgical …, 2023 - Wiley Online Library
Abstract Background and Objectives There are no guidelines for intravenous fluid (IVF)
administration after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
administration after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
Standardised Critical Care Strategies Improve Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in an Indian Peritoneal …
D Chandramohan, F Mohamed, S Vikram… - Indian Journal of …, 2023 - Springer
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a
major undertaking with profound peri-operative metabolic and haemodynamic alterations. It …
major undertaking with profound peri-operative metabolic and haemodynamic alterations. It …
Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a …
JP Cata, AM Zavala, A Van Meter… - International Journal …, 2018 - Taylor & Francis
Background: Acute kidney injury (AKI) is a postoperative complication associated with
significant morbidity and mortality. The incidence and risks factors for AKI after cytoreductive …
significant morbidity and mortality. The incidence and risks factors for AKI after cytoreductive …
Enhanced recovery after surgery is safe for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
RCG Martin II, BM Marshall, P Philips, M Egger… - The American Journal of …, 2020 - Elsevier
Introduction Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-
HIPEC) is an effective, aggressive approach to treating intraperitoneal carcinomatosis. This …
HIPEC) is an effective, aggressive approach to treating intraperitoneal carcinomatosis. This …
A comparison of two techniques of postoperative analgesia: lignocaine-fentanyl intravenous infusion and ropivacaine-fentanyl epidural infusion in patients undergoing …
Background Extensive surgical dissection, hemodynamic alterations associated with
cytoreductive surgery (CRS), and hyperthermic intraperitoneal chemotherapy (HIPEC) make …
cytoreductive surgery (CRS), and hyperthermic intraperitoneal chemotherapy (HIPEC) make …
[HTML][HTML] The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
R Shamavonian, R McLachlan, OM Fisher… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background Determine the effect of intraoperative fluids (IOFs) administered during
cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on …
cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on …
Feasibility and benefits of an enhanced recovery after surgery protocol for patients undergoing cytoreductive surgery and heated intraperitoneal chemotharpy: a single …
R Siddharthan, E Dewey, K Billingsley, E Gilbert… - The American Journal of …, 2020 - Elsevier
Abstract Background Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal
Chemotherapy (HIPEC) is reported to have a prolonged length of stay (LOS). We …
Chemotherapy (HIPEC) is reported to have a prolonged length of stay (LOS). We …
Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity
S Kusamura, D Baratti, R Younan, B Laterza… - Annals of Surgical …, 2007 - Springer
Introduction The purpose of this study was to analyze the postoperative systemic toxicity and
procedure-related mortality (PRM) of cytoreductive surgery (CRS) and hyperthermic …
procedure-related mortality (PRM) of cytoreductive surgery (CRS) and hyperthermic …
[HTML][HTML] Postoperative complications and critical care management after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy: A systematic review of …
AS Wajekar, SL Solanki, VP Patil - World Journal of Critical Care …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Cytoreductive surgery (CRS) and hyperthermic intraperitoneal
chemotherapy (HIPEC) is a comprehensive treatment option performed for peritoneal …
chemotherapy (HIPEC) is a comprehensive treatment option performed for peritoneal …